Nanjing Medlander Medical Technology Co. Ltd. A (688273) — Working Capital to Net Assets Ratio
Nanjing Medlander Medical Technology Co. Ltd. A (688273) has a Working Capital to Net Assets ratio of 58.9% as of June 2025. Working capital of CN¥803.93 Million (current assets of CN¥920.81 Million minus current liabilities of CN¥116.88 Million) is measured against net assets of CN¥1.36 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Nanjing Medlander Medical Technology Co. balance sheet independence to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Nanjing Medlander Medical Technology Co. Ltd. A Working Capital to Net Assets (2020–2024)
This chart shows how Nanjing Medlander Medical Technology Co. Ltd. A's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2020 to 2024. As of June 2025, the ratio stands at 58.9%, reflecting working capital of CN¥803.93 Million against net assets of CN¥1.36 Billion CNY. Check Nanjing Medlander Medical Technology Co. tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Nanjing Medlander Medical Technology Co. Ltd. A (2020–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Nanjing Medlander Medical Technology Co. Ltd. A from 2020 to 2024, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 688273 stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 62.3% | CN¥838.70 Million | CN¥1.35 Billion | CN¥1.00 Billion | CN¥162.96 Million | ▼ -13.3 pp |
| 2023 | 75.5% | CN¥1.04 Billion | CN¥1.38 Billion | CN¥1.17 Billion | CN¥133.24 Million | ▼ -11.9 pp |
| 2022 | 87.4% | CN¥1.20 Billion | CN¥1.37 Billion | CN¥1.32 Billion | CN¥123.55 Million | ▲ +22.7 pp |
| 2021 | 64.7% | CN¥241.17 Million | CN¥372.74 Million | CN¥341.28 Million | CN¥100.11 Million | ▲ +19.0 pp |
| 2020 | 45.7% | CN¥113.05 Million | CN¥247.47 Million | CN¥197.57 Million | CN¥84.52 Million | — |